Bvf Inc Delcath Systems, Inc. Transaction History
Bvf Inc
- $3.34 Billion
- Q1 2024
A detailed history of Bvf Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,202,067 shares of DCTH stock, worth $9.89 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,202,067
Previous 976,149
23.14%
Holding current value
$9.89 Million
Previous $4.06 Million
41.21%
% of portfolio
0.17%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding DCTH
# of Institutions
42Shares Held
7.34MCall Options Held
148KPut Options Held
60.8K-
Aigh Capital Management LLC Baltimore, MD2.36MShares$19.4 Million4.54% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.67MShares$13.7 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA684KShares$5.63 Million0.0% of portfolio
-
Cibc World Market Inc. Toronto, A6260KShares$2.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA223KShares$1.84 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $70.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...